Current Infectious Disease Reports

, Volume 8, Issue 1, pp 51–58 | Cite as

Leptospirosis in the tropics and in travelers



Leptospirosis, caused by spirochetes of the genus Leptospira, has increasingly been recognized to affect travelers and residents in tropical settings. A zoonotic disease, leptospirosis is transmitted to humans through environmental surface waters contaminated by the urine of chronically infected mammals. Outcome of infection varies, ranging from acute febrile illness (including selfresolving undifferentiated fever) to aseptic meningitis to a fulminant syndrome of jaundice, oliguric renal failure, pulmonary hemorrhage, and refractory shock. Hospitalized cases have mortality rates as high as 25%. A recent clinical trial showed that third-generation cephalosporin is as effective as doxycycline and penicillin in the treatment of acute disease. Doxycycline is effective in preventing leptospirosis in travelers. No protective vaccine is currently available.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Yersin C, Bovet P, Merien F, et al.: Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles. Trans R Soc Trop Med Hyg 2000, 94:71–76.PubMedCrossRefGoogle Scholar
  2. 2.
    Trevejo RT, Rigau-Perez JG, Ashford DA, et al.: Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis 1998, 178:1457–1463.PubMedCrossRefGoogle Scholar
  3. 3.
    Marotto PC, Nascimento CM, Eluf-Neto J, et al.: Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999, 29:1561–1563.PubMedCrossRefGoogle Scholar
  4. 4.
    Segura E, Ganoza C, Campos K, et al.: Clinical spectrum of pulmonary involvement in leptospirosis in an endemic region, with quantification of leptospiral burden. Clin Infect Dis 2005, 40:343–351. This population-based study demonstrated the urban association of severe disease in the tropical setting and delineated a spectrum of pulmonary manifestations in severe disease. A higher leptospiral burden, quantified using a real-time PCR assay, was associated with poor outcome.PubMedCrossRefGoogle Scholar
  5. 5.
    Vinetz JM, Glass GE, Flexner CE, et al.: Sporadic urban leptospirosis. Ann Intern Med 1996, 125:794–798.PubMedGoogle Scholar
  6. 6.
    Thiermann AB, Frank RR: Human leptospirosis in Detroit and the role of rats as chronic carriers. Int J Zoonoses 1980, 7:62–72.PubMedGoogle Scholar
  7. 7.
    Sehgal SC, Vijayachari P, Murhekar MV, et al.: Leptospiral infection among primitive tribes of Andaman and Nicobar Islands. Epidemiol Infect 1999, 122:423–428.PubMedCrossRefGoogle Scholar
  8. 8.
    Vijayachari V, Sugunan AP, Murhekar MV, et al.: Leptospirosis among schoolchildren of the Andaman & Nicobar Islands, India: low levels of morbidity and mortality among pre-exposed children during an epidemic. Epidemiol Infect 2004, 132:1115–1120. This paper is among the first to demonstrate, on a population level, that protective immunity develops in humans.PubMedCrossRefGoogle Scholar
  9. 9.
    Centers for Disease Control and Prevention: Outbreak of leptospirosis among white-water rafters—Costa Rica, 1996. MMWR Mor Mortal Wkly Rep 1997, 46:577–579.Google Scholar
  10. 10.
    Sejvar J, Bancroft E, Winthrop K, et al.: Leptospirosis in Eco-Challenge athletes, Malaysian Borneo, 2000. Emerg Infect Dis 2003, 9:702–707.PubMedGoogle Scholar
  11. 11.
    van Creel R, Speelman P, Gravekamp C, Terpstra WJ: Leptospirosis in travelers. Clin Infect Dis 1994, 19:132–134.Google Scholar
  12. 12.
    Kager PA, van Gorp EC, van Thiel PP: Fever and chills due to leptospirosis after travel to Thailand. Ned Tijdschr Geneeskd 2001, 145:184–186.PubMedGoogle Scholar
  13. 13.
    Olszyna DP, Jaspars R, Speelman P, et al.: Leptospirosis in the Netherlands, 1991–1995. Ned Tijdschr Geneeskd 1998, 142:1270–1273.PubMedGoogle Scholar
  14. 14.
    Russell KL, Montiel Gonzalez MA, et al.: An outbreak of leptospirosis among Peruvian military recruits. Am J Trop Med Hyg 2003, 69:53–57.PubMedGoogle Scholar
  15. 15.
    Sanders L: Diagnosis. The New York Times Magazine. April 24, 2005: 6, 35.Google Scholar
  16. 16.
    Torten M, Marshell RB: Leptospirosis. In Handbook of Zoonoses, edn 2. Section A: Bacterial, Rickettsial, Chlamydial and Mycotic Zoonoses. Edited by Beran GW and Steele JH. Boca Raton, FL: CRC Press; 1994:245–264.Google Scholar
  17. 17.
    Faine S, Adler B, Bolin C, Perolat P: Leptospira and Leptospirosis, 2nd edn. Melbourne: Medisci; 1999.Google Scholar
  18. 18.
    Bharti AR, Nally JE, Ricaldi JN, et al.: Leptospirosis: A zoonotic disease of global importance. Lancet Infect Dis 2003, 3:757–771.PubMedCrossRefGoogle Scholar
  19. 19.
    McBride AJ, Athanazio DA, Reis MG, Ko AI: Leptospirosis. Curr Opin Infect Dis 2005, 18:376–386. This is the most up-to-date review of leptospirosis from the basic research point of view.PubMedCrossRefGoogle Scholar
  20. 20.
    Palmer MF, Zochowski WJ: Survival of leptospires in commercial blood culture systems revisited. J Clin Pathol 2000, 53:713–714.PubMedCrossRefGoogle Scholar
  21. 21.
    Chandrasekaran S, Krishnaveni S, Chandrasekaran N:Darkfield microscopic (DFM) and serologic evidences for leptospiral infection in panuveitis cases. Indian J Med Sci 1998, 52:294–298.PubMedGoogle Scholar
  22. 22.
    Vijayachari P, Sugunan AP, Umapathi T, Sehgal SC:Evaluation of darkground microscopy as a rapid diagnostic procedure in leptospirosis. Indian J Med Res 2001, 114:54–58.PubMedGoogle Scholar
  23. 23.
    Gelman SS, Gundlapalli AV, Hale D, et al.: Spotting the spirochete: rapid diagnosis of leptospirosis in two returned travelers. J Travel Med 2002, 9:165–167.PubMedCrossRefGoogle Scholar
  24. 24.
    Rao PS, Shashibhushan, Shivananda PG: Comparison of darkground microscopy with serological tests in the diagnosis of leptospirosis with hepatorenal involvement —A preliminary study. Indian J Pathol Microbiol 1998, 41:427–429.PubMedGoogle Scholar
  25. 25.
    Levett PN: Leptospira and Leptonema. In Manual of Clinical Microbiology, edn 8. Edited by Murray PR. Washington, D.C.: ASM Press; 2003:929–936.Google Scholar
  26. 26.
    Matsuo K, Isogai E, Araki Y: Occurrence of [--> 3)-beta-D-Manp-(1 --> 4)-beta-D-Manp-(1 -->]n units in the antigenic polysaccharides from Leptospira biflexa serovar patoc strain Patoc I. Carbohydr Res 2000, 328:517–524.PubMedCrossRefGoogle Scholar
  27. 27.
    Terpstra WJ, Ligthart GS, Schoone GJ: ELISA for the detection of specific IgM and IgG in human leptospirosis. J Gen Microbiol 1985, 131:377–385.PubMedGoogle Scholar
  28. 28.
    Effler PV, Domen HY, Bragg SL, et al.: Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis in Hawaii. J Clin Microbiol 2000, 38:1081–1084.PubMedGoogle Scholar
  29. 29.
    Bajani MD, Ashford DA, Bragg SL, et al.: Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol 2003, 41:803–809. This paper comprehensively compares the sensitivity and of the most recent solid phase assays for the diagnosis of leptospirosis. It may not be applicable to the diagnosis of leptospirosis in the endemic setting where leptospirosis is very common.PubMedCrossRefGoogle Scholar
  30. 30.
    Smits HL, Hartskeerl RA, Terpstra WJ: International multi-centre evaluation of a dipstick assay for human leptospirosis. Trop Med Int Health 2000, 5:124–128.PubMedCrossRefGoogle Scholar
  31. 31.
    Smits HL, van der Hoorn MA, Goris MG, et al.: Simple latex agglutination assay for rapid serodiagnosis of human leptospirosis. J Clin Microbiol 2000, 38:1272–1275.PubMedGoogle Scholar
  32. 32.
    Hatta M, Smits HL, Gussenhoven GC, Gooskens J:Introduction of a rapid dipstick assay for the detection of Leptospira-specific immunoglobulin m antibodies in the laboratory diagnosis of leptospirosis in a hospital in Makassar, Indonesia. Southeast Asian J Trop Med Public Health 2000, 31:515–520.PubMedGoogle Scholar
  33. 33.
    Smits HL, Chee HD, Eapen CK, et al.: Latex based, rapid and easy assay for human leptospirosis in a single test format. Trop Med Int Health 2001, 6:114–118.PubMedCrossRefGoogle Scholar
  34. 34.
    Smits HL, Eapen CK, Sugathan S, et al.: Lateral-.ow assay for rapid serodiagnosis of human leptospirosis. Clin Diagn Lab Immunol 2001, 8:166–169.PubMedCrossRefGoogle Scholar
  35. 35.
    Levett PN, Branch SL: Evaluation of two enzyme-linked immunosorbent assay methods for detection of immunoglobulin M antibodies in acute leptospirosis. Am J Trop Med Hyg 2002, 66:745–748.PubMedGoogle Scholar
  36. 36.
    Merien F, Baranton G, Perolat P: Comparison of polymerase chain reaction with microagglutination test and culture for diagnosis of leptospirosis. J Infect Dis 1995, 172:281–285.PubMedGoogle Scholar
  37. 37.
    Truccolo J, Serais O, Merien F, Perolat P: Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol Lett 2001, 204:317–321.PubMedCrossRefGoogle Scholar
  38. 38.
    Merien F, Portnoi D, Bourhy P, et al.: A rapid and quantitative method for the detection of Leptospira species in human leptospirosis. FEMS Microbiol Lett 2005, 249:139–147.PubMedCrossRefGoogle Scholar
  39. 39.
    Suwimonteerabutr J, Chaicumpa W, Saengjaruk P, et al.:Evaluation of a monoclonal antibody-based dot-blot ELISA for detection of Leptospira spp in bovine urine samples. Am J Vet Res 2005, 66:762–766.PubMedCrossRefGoogle Scholar
  40. 40.
    Saengjaruk P, Chaicumpa W, Watt G, et al.: Diagnosis of human leptospirosis by monoclonal antibody-based antigen detection in urine. J Clin Microbiol 2002, 40:480–489.PubMedCrossRefGoogle Scholar
  41. 41.
    Haake DA, Dundoo M, Cader R, et al.: Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis 2002, 34:e40–43.PubMedCrossRefGoogle Scholar
  42. 42.
    Centers for Disease Control and Prevention: Update: outbreak of acute febrile illness among athletes participating in Eco-Challenge-Sabah 2000—Borneo, Malaysia, 2000. Morb Mortal Wkly Rep 2001, 50:21–24.Google Scholar
  43. 43.
    Morgan J, Bornstein SL, Karpati AM, et al.: Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 2002, 34:1593–1599.PubMedCrossRefGoogle Scholar
  44. 44.
    Ashford DA, Kaiser RM, Spiegel RA, et al.: Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg 2000, 63:249–254.PubMedGoogle Scholar
  45. 45.
    Rathinam SR, Rathnam S, Selvaraj S, et al.: Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol 1997, 124:71–79.PubMedGoogle Scholar
  46. 46.
    Spichler A, Moock M, Chapola EG, Vinetz JM: Weil’s Disease: an unusually fulminant presentation characterized by pulmonary hemorrhage and shock. Braz J Infect Dis 2005, 9:336–340.PubMedCrossRefGoogle Scholar
  47. 47.
    Wu MS, Yang CW, Pan MJ, et al.: Reduced renal Na+-K+-Cl-co-transporter activity and inhibited NKCC2 mRNA expression by Leptospira shermani: from bed-side to bench. Nephrol Dial Transplant 2004, 19:2472–2479.PubMedCrossRefGoogle Scholar
  48. 48.
    Burth P, Younes-Ibrahim M, Santos MC, et al.: Role of nonesterified unsaturated fatty acids in the pathophysiological processes of leptospiral infection. J Infect Dis 2005, 191:51–57.PubMedCrossRefGoogle Scholar
  49. 49.
    Yang CW, Wu MS, Pan MJ, et al.: Leptospira outer membrane protein activates NF-kappaB and downstream genes expressed in medullary thick ascending limb cells. J Am Soc Nephrol 2000, 11:2017–2026.PubMedGoogle Scholar
  50. 50.
    Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al.: A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant 2003, 18:1128–1134.PubMedCrossRefGoogle Scholar
  51. 51.
    Sehgal SC, Murhekar MV, Sugunan AP: Outbreak of leptospirosis with pulmonary involvement in north Andaman. Indian J Med Res 1995, 102:9–12.PubMedGoogle Scholar
  52. 52.
    Ko Galvao Reis M, Ribeiro Dourado CM, et al.: Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 1999, 354:820–825. This paper is an important advance in our epidemiologic understanding of leptospirosis in the tropical urban setting.Google Scholar
  53. 53.
    Goncalves AJ, de Carvalho JE, Guedes ne Silva JB, et al.:Hemoptysis and the adult respiratory distress syndrome as the causes of death in leptospirosis. Changes in the clinical and anatomicopathological patterns (in Portuguese). Rev Soc Bras Med Trop 1992, 25:261–270.PubMedGoogle Scholar
  54. 54.
    Silva JJ, Dalston MO, Carvalho JE, et al.: Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 2002, 35:395–399.PubMedGoogle Scholar
  55. 55.
    Nally JE, Chantranuwat C, Wu XY, et al.: Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 2004, 164:1115–1127.PubMedGoogle Scholar
  56. 56.
    Nally JE, Fishbein MC, Blanco DR, Lovett MA: Lethal infection of C3H/HeJ and C3H/SCID mice with an isolate of Leptospira interrogans serovar copenhageni. Infect Immun 2005, 73:7014–7017.PubMedCrossRefGoogle Scholar
  57. 57.
    Watt G, Padre LP, Tuazon ML, et al.: Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988, 1:433–435.PubMedCrossRefGoogle Scholar
  58. 58.
    Edwards CH, Nicholson GD, Hassell TA, et al.: Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg 1988, 39:388–390.PubMedGoogle Scholar
  59. 59.
    Vinetz JM: A mountain out of a molehill: Do we treat acute leptospirosis and, if so, with what? Clin Infect Dis 2003, 36:1514–1515.PubMedCrossRefGoogle Scholar
  60. 60.
    Panaphut J, Domrongkitchaiporn S, Thinkamrop B: Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 2002, 6:52–59. Despite being an open-label study, this paper validates the use of ceftriaxone in the treatment of severe leptospirosis and provides solid evidence that antibiotic therapy is required for severe leptospirosis.PubMedCrossRefGoogle Scholar
  61. 61.
    Murray CK, Hospenthal DR: Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob Agents Chemother 2004, 48:4002–4005.PubMedCrossRefGoogle Scholar
  62. 62.
    Borer A, Metz I, Gilad J, et al.: Massive pulmonary haemorrhage caused by leptospirosis successfully treated with nitric oxide inhalation and haemofiltration. J Infect 1999, 38:42–45.PubMedCrossRefGoogle Scholar
  63. 63.
    Siriwanij T, Suttinont C, Tantawichien T, et al.: Haemodynamics in leptospirosis: effects of plasmapheresis and continuous venovenous haemofiltration. Nephrology (Carlton) 2005, 10:1–6.CrossRefGoogle Scholar
  64. 64.
    Tse KC, Yip PS, Hui KM, et al.: Potential benefit of plasma exchange in treatment of severe icteric leptospirosis complicated by acute renal failure. Clin Diagn Lab Immunol 2002, 9:482–484.PubMedCrossRefGoogle Scholar
  65. 65.
    Feigin RD, Lobes LA, Anderson D, Pickering L: Human leptospirosis from immunized dogs. Ann Intern Med 1973, 79:777–785.PubMedGoogle Scholar
  66. 66.
    Talpada MD, Garvey N, Sprowls R, et al.: Prevalence of Leptospiral infection in Texas cattle: implications for transmission to humans. Vector Borne Zoonotic Dis 2003, 3:141–147.PubMedCrossRefGoogle Scholar
  67. 67.
    Barcellos C, Sabroza PC: The place behind the case: leptospirosis risks and associated environmental conditions in a flood-related outbreak in Rio de Janeiro. Cad Saude Publica 2001, 17(Suppl):59–67.PubMedGoogle Scholar
  68. 68.
    Vanasco NB, Fusco S, Zanuttini JC, et al.: Outbreak of human leptospirosis after a flood in Reconquista, Santa Fe, 1998. Rev Argent Microbiol 2002, 34:124–131.PubMedGoogle Scholar
  69. 69.
    Takafuji ET, Kirkpatrick JW, Miller RN, et al.: An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984, 310:497–500.PubMedCrossRefGoogle Scholar
  70. 70.
    Sehgal SC, Sugunan AP, Murhekar MV, et al.: Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents 2000, 13:249–255.PubMedCrossRefGoogle Scholar
  71. 71.
    Langston CE, Heuter KJ: Leptospirosis. A re-emerging zoonotic disease. Vet Clin North Am Small Anim Pract 2003, 33:791–807.PubMedCrossRefGoogle Scholar
  72. 72.
    Martinez Sanchez R, Perez Sierra A, Baro Suarez M, et al.:Evaluation of the effectiveness of a new vaccine against human leptospirosis in groups at risk. Rev Panam Salud Publica 2000, 8:385–392.CrossRefGoogle Scholar
  73. 73.
    Yan Y, Chen Y, Liou W, et al.: An evaluation of the serological and epidemiological effects of the outer envelope vaccine to leptospira. J Chin Med Assoc 2003, 66:224–230.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Division of Infectious Diseases, Department of MedicineUniversity of California San Diego School of MedicineLa JollaUSA

Personalised recommendations